Clinical Trials Browser

Completed × Lung Neoplasms × Sunitinib × Clear all

NCT01829217 2018-10-31

Sunitinib in Never-Smokers With Lung Adenocarcinoma

Phase 2 Completed

13 enrolled 5 charts

Lung Neoplasms

NCT01402089 2016-02-02

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Phase 4 Completed

GastrointestinalGenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Gastrointestinal Stromal Tumors

NCT00620347 2013-06-19

Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00430261 2010-10-06

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

Phase 2 Completed

Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Lung Neoplasms

NCT00113516 2010-05-18

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

84 enrolled 40 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00712504 2008-11-11

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms